Thalamic pain
Conditions
Interventions
Sham stimulation group:Conventional medication treatment (Pregabalin, oral 150mg/time, 2 times/day)+head mounted device without effective stimulation
tTIS group:Conventional drug treatment (pregabalin, 150 mg/time orally, 2 times/day) + tTIS treatment
Sponsors
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Eligibility
Sex/Gender
All
Age
40 Years to 75 Years
Inclusion criteria
Inclusion criteria: Diagnosed with thalamic pain and ineffective or intolerant to conventional drug treatment; 40-75 years old; ASA Level I-II; Visual Analog Scale (VAS) score >=3 points; Patient or family member signs informed consent form.
Exclusion criteria
Exclusion criteria: Accompanied by other chronic pain disorders; Combined with severe liver and kidney function damage; Has obvious mental disorders; Has severe anxiety and depression; Accompanied by epilepsy; Arrhythmia; Metal placement in the body after brain surgery; Pregnant women; History of drug abuse; Participate in clinical studies related to other pain treatments; TTIS treatment contraindications; Refusing to cooperate for other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain Visual Analog Scale (VAS); | — |
Secondary
| Measure | Time frame |
|---|---|
| Brief pain inventory, BPI;Self-Rating Depression Scale, SDS;Self-Rating Anxiety Scale, SAS;Pittsburgh sleep quality index, PSQI;EQ5D;electroencephalogram, ECG; | — |
Countries
China
Contacts
Public Contactxuebi tian
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Outcome results
None listed